Site Map

Interstitial lung disease

Diffuse parenchymal lung disease; Alveolitis; Idiopathic pulmonary pneumonitis (IPP)

Interstitial lung disease (ILD) is a group of lung disorders in which the lung tissues become inflamed and then damaged.

Images

Clubbing
Coal workers pneumoconiosis - stage II
Coal workers pneumoconiosis - stage II
Coal workers pneumoconiosis, complicated
Respiratory system

I Would Like to Learn About:

Causes

The lungs contain tiny air sacs (alveoli), which is where oxygen is absorbed. These air sacs expand with each breath.

The tissue around these air sacs is called the interstitium. In people with interstitial lung disease, this tissue becomes inflamed, stiff, or scarred, and the air sacs are not able to expand as much. As a result, not as much oxygen can get to the body.

ILD can occur without a known cause. This is called idiopathic ILD. Idiopathic pulmonary fibrosis (IPF) is the most common disease of this type.

There are also dozens of known causes of ILD, including:

Cigarette smoking may increase the risk of developing some forms of ILD and may cause the disease to be more severe.

Symptoms

Shortness of breath is a main symptom of ILD. You may breathe faster or need to take deep breaths:

Most people with this condition also have a dry cough. A dry cough means you do not cough up any mucus or sputum.

Over time, weight loss, fatigue, and muscle and joint pain are also present.

People with more advanced ILD may have:

Exams and Tests

Your health care provider will perform a physical exam. Dry, crackling breath sounds may be heard when listening to your chest with a stethoscope.

The following tests may be done:

People who are heavily exposed to known causes of lung disease in the workplace are usually routinely screened for lung disease. These jobs include coal mining, sand blasting, and working on a ship.

Treatment

Treatment depends on the cause and duration of the disease. Medicines that suppress the immune system and reduce swelling in the lungs are prescribed if an autoimmune disease is causing the problem. For some people who have IPF or certain other autoimmune diseases, pirfenidone and nintedanib are two medicines that may be used to slow worsening of the disease. If there is no specific treatment for the condition, the aim is to make you more comfortable and support lung function:

Lung rehabilitation can provide support, and help you learn:

Some people with advanced ILD may need a lung transplant.

Support Groups

You can ease the stress of illness by joining a support group. Sharing with others who have common experiences and problems can help you not feel alone.

Outlook (Prognosis)

The chance of recovering or ILD getting worse depends on the cause and how severe the disease was when it was first diagnosed.

Some people with ILD develop heart failure and high blood pressure in the blood vessels of their lungs (pulmonary hypertension).

Idiopathic pulmonary fibrosis has a poor outlook.

When to Contact a Medical Professional

Contact your provider if:

Related Information

Breathing difficulty
Blue discoloration of the skin
Pulmonary hypertension
Interstitial lung disease - adults - discharge
Using oxygen at home
Oxygen safety
How to breathe when you are short of breath
Traveling with breathing problems

References

Corte TJ, Wells AU. Connective tissue diseases. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 92.

Graney BA, Lee JS, King TE. Nonspecific interstitial pneumonitis and other idiopathic interstitial pneumonias. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 90.

Raghu G, Martinez FJ. Interstitial lung disease. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 80.

BACK TO TOP

Review Date: 11/25/2023  

Reviewed By: Denis Hadjiliadis, MD, MHS, Paul F. Harron, Jr. Professor of Medicine, Pulmonary, Allergy, and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo
Health Content Provider
06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.